ReviewMaterials today. Bio2026
Biomaterial-assisted gene therapy for bone repair.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Extracellular matrix-mimic nanofibrous microspheres: fabrication and application in stem cell delivery for tissue repair and regeneration.Materials today. Bio · 2026Review
- Biochemical and Physicomechanical Cues of Biomaterials Guide Osteogenic Differentiation of Mesenchymal Stem Cells.International journal of molecular sciences · 2026Review
- From Nature to Innovation: Exploring Natural Biopolymers in 3D Bioprinting for Bone Regeneration.ACS omega · 2026Article
- Pitaya‑inspired compartmentalized microspheres with natural tannic acid-copper coating orchestrate smart release of ions and multi-drugs for synergistic treatment of infected bone defects.Regenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone defects are a prevalent and serious condition that can give rise to pain, deformity, infection, and even serious consequences. However, conventional treatment modalities, whether conservative or surgical, are often limited by suboptimal outcomes, insufficient resources, or potential risks. Biomaterial-assisted gene therapy systems, an emerging interdisciplinary field integrating gene therapy and biomaterial technology, enhance gene therapy targeting, cellular uptake, and gene expression efficiency, facilitating a shift from natural bone grafts to artificial biomaterial substitutes. Below, we present a comprehensive review of current developments in biomaterial-assisted gene therapy for bone repair. Following a brief introduction of bone repair mechanisms and conventional treatment strategies, the foundations of biomaterial-assisted gene therapy for bone repair are elucidated from a holistic perspective, highlighting the three key elements: therapeutic genes, gene vectors, and biomaterials. Furthermore, current challenges and future research directions are discussed. The review is not confined to the summary of a single technology; rather, it aims to establish an overarching concept of biomaterial-assisted gene therapy and serve as a reference for future interdisciplinary studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.